€2.44
Your prediction
Minerva Neurosciences Inc. Stock
Minerva Neurosciences (NASDAQ: NERV) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients suffering from neuropsychiatric disorders. With a primary emphasis on central nervous system diseases such as schizophrenia, major depressive disorder, insomnia, and Parkinson's, Minerva Neurosciences is committed to addressing unmet medical needs and advancing the understanding of the underlying biology of these conditions. Utilizing a strong research and development platform, the company aims to create a diversified portfolio of novel therapies that have the potential to significantly improve patients' quality of life and help them lead more fulfilling lives.
Pros and Cons of Minerva Neurosciences Inc. in the next few years
Pros
Cons
Performance of Minerva Neurosciences Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Minerva Neurosciences Inc. | 3.250% | 0.000% | 3.390% | -66.982% | -58.183% | -82.441% | - |
Evolus Inc | 1.410% | -3.472% | -0.714% | 64.497% | 53.591% | 107.463% | - |
Ardelyx Inc. | 2.640% | 2.366% | -3.845% | 48.152% | -5.675% | 370.000% | 16.297% |
Brainstorm Cell | 2.590% | 0.235% | -29.470% | -71.974% | -5.752% | -92.604% | -94.112% |
Comments